| Disparities in Mental Health Screening and Support (NCT07691281) | European Institute of Oncology | 2026-07-15 |
| MELanoma Brain Metastasis Treated With CYberknife (NCT07691255) | European Institute of Oncology | 2026-06-01 |
| Endoscopic Video-Assisted Nipple-Sparing Mastectomy (NCT07579117) | European Institute of Oncology | 2026-05-23 |
| Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE) (NCT07395336) | European Institute of Oncology | 2026-05-11 |
| Patient Anxiety During Magnetic Resonance Imaging (NCT07671846) | European Institute of Oncology | 2026-05-06 |
| Cognitive Impairment Assessment in Breast Cancer Survivors (NCT07582770) | European Institute of Oncology | 2026-05-01 |
| DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER (NCT07690540) | European Institute of Oncology | 2026-04-14 |
| Dietary Quality and Nutritional Adequacy Among Vegetarians Attending the European Institute of Oncology (NCT07638839) | European Institute of Oncology | 2026-03-26 |
| Germline Genetic Testing of the TP53 Gene (NCT07419893) | European Institute of Oncology | 2026-01-29 |
| Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement (NCT07278726) | European Institute of Oncology | 2026-01-28 |
| Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer (NCT07066969) | European Institute of Oncology | 2026-01-22 |
| IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCER (NCT07374809) | European Institute of Oncology | 2026-01-21 |
| Sexual Well-being of Women Undergoing Mastectomy and Reconstruction (NCT07234461) | European Institute of Oncology | 2026-01-21 |
| CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors (NCT07429851) | European Institute of Oncology | 2026-01-01 |
| Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site (NCT07325864) | European Institute of Oncology | 2025-12-18 |
| Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC (NCT07080944) | European Institute of Oncology | 2025-12-12 |
| Minimal Residual Disease in Solid Malignancies (NCT07268469) | European Institute of Oncology | 2025-12-01 |
| Role of the Immune System in Preventing Laryngeal Cancer (NCT07508319) | European Institute of Oncology | 2025-11-19 |
| Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors: (NCT07180693) | European Institute of Oncology | 2025-09-29 |
| Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer (NCT07049133) | European Institute of Oncology | 2025-07-31 |
| Personalization of External Beam Radiation Therapy in Localised Tumours (NCT07047495) | European Institute of Oncology | 2025-07-01 |
| Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy (NCT06994377) | European Institute of Oncology | 2025-06-25 |
| Real-WorlD ZolbetUximab in Patients With HER-2 Negative and CLaudin 18.2 PosItive MetastatiC AdEnocarcinoma (NCT07427992) | European Institute of Oncology | 2025-06-20 |
| Digital Solutions for bEtter cAre (NCT07416513) | European Institute of Oncology | 2025-05-14 |
| Prevention of Capsular Contracture in Postmastectomy Patients Undergoing Implant-based Reconstructions (NCT06785610) | European Institute of Oncology | 2025-04-08 |
| Robotic Nipple Sparing Mastectomy with Immediate Reconstruction (NCT06860217) | European Institute of Oncology | 2025-04-01 |
| Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients (NCT06690840) | European Institute of Oncology | 2025-03-06 |
| Hemopatch Implication After Axillary Dissection for Breast Cancer (NCT06744998) | European Institute of Oncology | 2025-02-01 |
| A New Tool to Promote Patient's Engagement in Their Healthcare Process (NCT06762496) | European Institute of Oncology | 2025-01-22 |
| Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance (NCT06773650) | European Institute of Oncology | 2025-01-08 |
| Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration (NCT06762379) | European Institute of Oncology | 2024-12-20 |
| Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients, (NCT06762483) | European Institute of Oncology | 2024-12-20 |
| Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer (NCT06611514) | European Institute of Oncology | 2024-12-01 |
| PICC-ports Versus Chest - Ports for Long Term Chemotherapy Deliverance in Oncology Patients (NCT06541301) | European Institute of Oncology | 2024-12-01 |
| PIK3CA Mutational Status Assessment (NCT06706570) | European Institute of Oncology | 2024-11-06 |
| Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer (NCT06790264) | European Institute of Oncology | 2024-11-01 |
| High Definition Profiling of Ovarian Cancer Ascites (NCT06553742) | European Institute of Oncology | 2024-11-01 |
| Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma (NCT06566404) | European Institute of Oncology | 2024-10-30 |
| Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX (NCT06723990) | European Institute of Oncology | 2024-10-24 |
| EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms (NCT06785597) | European Institute of Oncology | 2024-10-21 |
| Physical Activity and Sarcoma, Role and Impact on Outcome (NCT06565858) | European Institute of Oncology | 2024-09-30 |
| IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4 (NCT06703567) | European Institute of Oncology | 2024-09-06 |
| Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer (NCT06610565) | European Institute of Oncology | 2024-09-01 |
| Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage Breast Cancer (NCT06474975) | European Institute of Oncology | 2024-07-01 |
| Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion (NCT06033092) | European Institute of Oncology | 2024-06-21 |
| Evaluation of the PreCursor-M+® in CIN2 (NCT06403618) | European Institute of Oncology | 2024-06-17 |
| Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy (NCT06422949) | European Institute of Oncology | 2024-06-15 |
| Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients (NCT06474988) | European Institute of Oncology | 2024-05-27 |
| Percutaneous Cryoablation of Low-risk Early Breast Cancer (NCT06300125) | European Institute of Oncology | 2024-04-15 |
| Psychological Assessment in Patients Treated with Spinal Cord Stimulation (NCT06761300) | European Institute of Oncology | 2024-04-09 |
| Profiling and Targeting Epigenetic Marks to Improve Diagnosis and Therapeutic Approaches in Head and Neck Cancer (NCT06706973) | European Institute of Oncology | 2024-03-06 |
| Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients (NCT06726889) | European Institute of Oncology | 2024-01-25 |
| Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer (NCT06706557) | European Institute of Oncology | 2024-01-11 |
| Cognitive Screening in Lung Cancer Patients (NCT06727370) | European Institute of Oncology | 2024-01-10 |
| Multimedia-assisted Informed Consent Procedure for Patients Undergoing Mastectomy and Implant-based Reconstruction (NCT06541223) | European Institute of Oncology | 2024-01-02 |
| Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery (NCT06281210) | European Institute of Oncology | 2023-12-11 |
| CARDIOCARE Prospective Clinical Study (NCT06334445) | European Institute of Oncology | 2023-09-14 |
| MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer (NCT05974475) | European Institute of Oncology | 2023-09-11 |
| Psychosexuological Interventions to Support Sexual Function in Breast Cancer Patients (NCT06327607) | European Institute of Oncology | 2023-06-09 |
| Pulsed Electromagnetic Fields for Analgesia Post Mastectomy (NCT06331793) | European Institute of Oncology | 2023-05-09 |
| Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer (NCT06341387) | European Institute of Oncology | 2023-05-05 |
| Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients (NCT06161181) | European Institute of Oncology | 2023-05-03 |
| Advanced Proton Therapy Approaches: a Multicenter High-quality Data Registry (NCT05860361) | European Institute of Oncology | 2023-04-14 |
| Radiosensitivity of HPV-related Tumors: Towards a Genomic Approach (NCT06321627) | European Institute of Oncology | 2023-04-14 |
| What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials (NCT06326242) | European Institute of Oncology | 2023-03-27 |
| YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. (NCT06337760) | European Institute of Oncology | 2023-03-10 |
| CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr (NCT06331013) | European Institute of Oncology | 2023-02-20 |
| Epigenomic and Machine Learning Models to Predict Pancreatic Cancer (NCT06334458) | European Institute of Oncology | 2023-02-03 |
| RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I) (NCT05963464) | European Institute of Oncology | 2023-02-01 |
| Excisional Vacuum-Assisted Breast Biopsy (NCT05932758) | European Institute of Oncology | 2023-01-17 |
| CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors (NCT06727383) | European Institute of Oncology | 2022-12-21 |
| Minimally Invasive Treatments of the Thyroid (NCT06333587) | European Institute of Oncology | 2022-10-10 |
| Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer (NCT06468293) | European Institute of Oncology | 2022-10-08 |
| A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer (NCT06343181) | European Institute of Oncology | 2022-10-03 |
| Study Evaluating Occupational Exposure to Antineoplastic Drugs (NCT06343103) | European Institute of Oncology | 2022-08-02 |
| Microbiome, Immune-system and Tumor Interaction in Colorectal Cancer (NCT06331988) | European Institute of Oncology | 2022-07-21 |
| Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. (NCT06321640) | European Institute of Oncology | 2022-07-08 |
| Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens (NCT06327568) | European Institute of Oncology | 2022-06-17 |
| LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients (NCT05410951) | European Institute of Oncology | 2022-05-16 |
| 68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET (NCT05448157) | European Institute of Oncology | 2022-05-12 |
| Verbal Synchrony, Satisfaction and Decision-making in Face-to-face Consultations (NCT06342739) | European Institute of Oncology | 2022-03-23 |
| Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy. (NCT05596851) | European Institute of Oncology | 2022-03-21 |
| Predicting Toxicity in Elderly Patients With Head and Neck Cancer (NCT06344208) | European Institute of Oncology | 2022-03-15 |
| Dissecting the Role of MIcrobioMe in gastroEsophageal Tumor: a multIdisCiplinary Longitudinal Study (NCT06405035) | European Institute of Oncology | 2022-03-08 |
| Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study (NCT05554003) | European Institute of Oncology | 2022-01-14 |
| Impact of Augmented Reality During Robot-assisted Radical Prostatectomy (NCT06059859) | European Institute of Oncology | 2022-01-01 |
| All-in-One Prostate Cancer Staging with MRI (NCT06071195) | European Institute of Oncology | 2021-12-22 |
| DOsimetry and Radiation Induced NAusea in Head and Neck Cancers (NCT06341985) | European Institute of Oncology | 2021-11-15 |
| Intervention Study in Prostate Cancer Patients Undergoing Radiotherapy (NCT05155618) | European Institute of Oncology | 2021-11-08 |
| Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer (NCT04679454) | European Institute of Oncology | 2021-07-31 |
| Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients (NCT06343428) | European Institute of Oncology | 2021-07-19 |
| PrognostIc and Predictive Factors in Unresectable Locally Advanced NEC and MANEC (NCT06400654) | European Institute of Oncology | 2021-07-05 |
| PrefeRences And ChemoTherapy In Breast Cancer patiEnts (NCT06332976) | European Institute of Oncology | 2021-06-04 |
| Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel (NCT06773624) | European Institute of Oncology | 2021-04-23 |
| Preoperative Lymph Node Staging With EBUS-TBNA in Clinical N0 Non Small-cell Lung Cancer (NCT04828850) | European Institute of Oncology | 2021-04-01 |
| ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases (NCT03448666) | European Institute of Oncology | 2021-03-01 |
| Value-Based Medicine (VBM) for Lung Cancer (NCT06703866) | European Institute of Oncology | 2021-01-27 |
| Promoting Men's Adherence to BRCA1/2 Germline Genetic Testing (NCT04683068) | European Institute of Oncology | 2021-01-10 |
| Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET) (NCT04720391) | European Institute of Oncology | 2021-01-08 |
| Evaluation of a Music and Interaction Intervention on Patient Distress During Whole Body Magnetic Resonance (NCT06332001) | European Institute of Oncology | 2020-12-31 |